Breaking News Instant updates and real-time market news.

HCDI

Harbor Custom Development

$2.78 /

-0.06 (-2.11%)

12:14
08/23/21
08/23
12:14
08/23/21
12:14

Harbor Custom Development to purchase Washington condominium site for $3.325M

Harbor Custom Development announced it contracted to purchase a 4.31 acre property permitted for the construction of 75 condominium units in Yelm, Washington for $3,325,000. Yelm is ideally located 22 miles from Washington State's capital of Olympia to the south and 32 miles north to the downtown Tacoma job market. Yelm offers easy access to several outdoor recreational opportunities such as the Yelm Tenino trail. Harbor anticipates the one-, two-and three-bedroom units will be priced starting in the low $300,000s and fill a significant need in the local marketplace.

  • 13

    Jan

TODAY'S FREE FLY STORIES

General news
U.S. home price previews » 02:05
09/28/21
09/28
02:05
09/28/21
02:05
$ECON

Economic Data

/

+

U.S. home price previews:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. Advance indicators preview » 02:05
09/28/21
09/28
02:05
09/28/21
02:05
$ECON

Economic Data

/

+

U.S. Advance indicators…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. consumer confidence preview » 02:05
09/28/21
09/28
02:05
09/28/21
02:05
$ECON

Economic Data

/

+

U.S. consumer confidence…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Asian Market Update: » 02:00
09/28/21
09/28
02:00
09/28/21
02:00
$ECON

Economic Data

/

+

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Treasury Market Summary » 22:40
09/27/21
09/27
22:40
09/27/21
22:40
$ECON

Economic Data

/

+

Treasury Market Summary:…

Treasury Market Summary: Treasuries extended their selloff but losses were pared after rates ran into resistance. The stronger than expected durable goods report added to the bearish momentum seen since last Wednesday's FOMC's hawkish pivot. The 10-year yield rose to challenge 1.51%, with the 30-year testing 2.04%, while the wi 5-year hit 1.005% before rates retreated from those key areas. Wall Street was mixed with the Dow in the green, advancing 0.2% after paring its gains. Strength in materials, energy, and financials supported. The NASDAQ and S&P 500 were lower, with the former leading the way, sliding -0.5% amid the pop in rates, while the S&P 500 was -0.28% lower. Along with data, Fedspeak all supported a likely start to QE tapering "soon." The various monetary and fiscal policy machinations limited demand for the Treasury's 2- and 5-year auctions, even as rates cheapened.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Mowi ASA initiated with an Overweight at Barclays » 20:38
09/27/21
09/27
20:38
09/27/21
20:38
MHGVY

Mowi ASA

$27.76 /

+0.23 (+0.84%)

Barclays analyst Alex…

Barclays analyst Alex Sloane initiated coverage of Mowi ASA with an Overweight rating and NOK 298 price target as part of a broader research note on Norwegian-based salmon farmers. The analyst states that the farmed salmon's health and wellness appeal, along with the sustainability advantages, should help underpin continued strong demand growth, though he also warns that new competition could emerge over the longer term. Sloane adds that he sees a positive inflection in Mowi's relative growth prospects and believes that its vertical integration in feed also provides advantages in terms of costs and sustainability.

ShowHide Related Items >><<
MHGVY Mowi ASA
$27.76 /

+0.23 (+0.84%)

09/08/21 Exane BNP Paribas
Mowi upgraded to Outperform from Neutral at Exane BNP Paribas
06/25/21 Kepler Cheuvreux
Mowi ASA downgraded to Hold from Buy at Kepler Cheuvreux
06/03/21 Nordea
Mowi ASA upgraded to Buy from Hold at Nordea
06/03/21 BofA
Mowi ASA upgraded to Buy from Neutral at BofA
Initiation
Leroy Seafood initiated with an Underweight at Barclays » 20:36
09/27/21
09/27
20:36
09/27/21
20:36
LYSFY

Leroy Seafood

$17.70 /

+ (+0.00%)

Barclays analyst Alex…

Barclays analyst Alex Sloane initiated coverage of Leroy Seafood with an Underweight rating and NOK 70 price target as part of a broader research note on Norwegian-based salmon farmers. The analyst states that the farmed salmon's health and wellness appeal, along with the sustainability advantages, should help underpin continued strong demand growth, though he also warns that new competition could emerge over the longer term. Leroy's wildcatch exposure is dilutive from both a financial and sustainability perspective, Sloane tells investors in a research note.

ShowHide Related Items >><<
LYSFY Leroy Seafood
$17.70 /

+ (+0.00%)

05/06/21 Fearnley
Leroy Seafood downgraded to Hold from Buy at Fearnley
Initiation
Salmar initiated with an Equal Weight at Barclays » 20:33
09/27/21
09/27
20:33
09/27/21
20:33
SALRF

Salmar

$67.95 /

+ (+0.00%)

Barclays analyst Alex…

Barclays analyst Alex Sloane initiated coverage of Salmar with an Equal Weight rating and NOK 596 price target as part of a broader research note on Norwegian-based salmon farmers. The analyst states that the farmed salmon's health and wellness appeal, along with the sustainability advantages, should help underpin continued strong demand growth, though he also warns that new competition could emerge over the longer term.

ShowHide Related Items >><<
SALRF Salmar
$67.95 /

+ (+0.00%)

09/06/21 Fearnley
Salmar upgraded to Buy from Hold at Fearnley
08/27/21 Pareto
Salmar upgraded to Buy from Hold at Pareto
08/27/21 DNB Markets
Salmar upgraded to Buy from Hold at DNB Markets
03/19/21 Berenberg
Salmar price target raised to NOK 580 from NOK 450 at Berenberg
Hot Stocks
Eisai, Biogen announce rolling FDA submission for lecanemab in early AD patients » 20:29
09/27/21
09/27
20:29
09/27/21
20:29
BIIB

Biogen

$286.71 /

-4.54 (-1.56%)

, ESALY

Eisai

$76.52 /

-1.24 (-1.59%)

Eisai (ESALY) and Biogen…

Eisai (ESALY) and Biogen (BIIB) announced that Eisai has initiated a rolling submission to the U.S. Food and Drug Administration FDA of a Biologics License Application for lecanemab, or BAN2401, the company's investigational anti-amyloid beta protofibril antibody, for the treatment of early Alzheimer's disease. The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology. The lecanemab Phase 2b trial results demonstrated a high degree of Abeta plaque lowering and consistent reduction of clinical decline across several clinical endpoints. The correlation between the extent of Abeta plaque reduction and effect on clinical endpoints in Study 201 further supports Abeta as a surrogate endpoint that is reasonably likely to predict clinical benefit. In June 2021, lecanemab was granted Breakthrough Therapy designation, which is an FDA program intended to expedite the development and review of medicines for serious or life threating conditions. Eisai has an agreement with the FDA to submit the BLA for lecanemab as a rolling submission. This agreement allows completed portions of the application to be submitted to the FDA for review on an ongoing basis.

ShowHide Related Items >><<
ESALY Eisai
$76.52 /

-1.24 (-1.59%)

BIIB Biogen
$286.71 /

-4.54 (-1.56%)

BIIB Biogen
$286.71 /

-4.54 (-1.56%)

09/27/21 Oppenheimer
Prothena price target raised to $100 from $90 at Oppenheimer
09/24/21 JPMorgan
Eli Lilly remains best positioned growth story in pharma, says JPMorgan
09/23/21 Mizuho
Biogen sales reps banned by D.C. neurology practice, says Mizuho
09/23/21 Cowen
CMS director telling states Aduhelm covered, restrictions can apply, says Cowen
ESALY Eisai
$76.52 /

-1.24 (-1.59%)

06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
11/05/20 Jefferies
Eisai upgraded to Buy from Hold at Jefferies
BIIB Biogen
$286.71 /

-4.54 (-1.56%)

ESALY Eisai
$76.52 /

-1.24 (-1.59%)

BIIB Biogen
$286.71 /

-4.54 (-1.56%)

ESALY Eisai
$76.52 /

-1.24 (-1.59%)

BIIB Biogen
$286.71 /

-4.54 (-1.56%)

BIIB Biogen
$286.71 /

-4.54 (-1.56%)

Hot Stocks
NOV Inc. announces retirement of Chief Accounting Officer » 20:04
09/27/21
09/27
20:04
09/27/21
20:04
NOV

NOV Inc.

$13.45 /

+0.495 (+3.82%)

NOV announced Scott Duff…

NOV announced Scott Duff Vice President, Corporate Controller and Chief Accounting Officer, notified the company of his intention to retire. Mr. Duff will step down from his current role effective November 1, 2021 and remain employed as an advisor until his retirement on February 28, 2022. Christy Novak will succeed Mr. Duff as Vice President, Corporate Controller and Chief Accounting Officer effective November 1, 2021.

ShowHide Related Items >><<
NOV NOV Inc.
$13.45 /

+0.495 (+3.82%)

NOV NOV Inc.
$13.45 /

+0.495 (+3.82%)

09/08/21 RBC Capital
NOV Inc. assumed with a Sector Perform at RBC Capital
07/19/21 BMO Capital
NOV Inc. upgraded to Market Perform from Underperform at BMO Capital
07/16/21 BofA
NOV Inc. upgraded to Buy from Neutral at BofA
07/15/21 Seaport Global
NOV Inc. initiated with a Buy at Seaport Global
NOV NOV Inc.
$13.45 /

+0.495 (+3.82%)

NOV NOV Inc.
$13.45 /

+0.495 (+3.82%)

Upgrade
Bouygues upgraded to Buy from Hold at Jefferies » 19:14
09/27/21
09/27
19:14
09/27/21
19:14
BOUYF

Bouygues

$42.20 /

+ (+0.00%)

Jefferies analyst Jeremy…

Jefferies analyst Jeremy Dellis upgraded Bouygues to Buy from Hold with a EUR 40 price target. The stock is trading at among the widest discounts seen in years, yet the company's growth prospects are robust and its forecast momentum is positive, the analyst tells investors in a research note. A special dividend decision expected this upcoming February could unlock EUR 45 level in shares "early next year", Dellis adds.

ShowHide Related Items >><<
BOUYF Bouygues
$42.20 /

+ (+0.00%)

08/27/21 Credit Suisse
Bouygues price target raised to EUR 39 from EUR 38 at Credit Suisse
08/13/21 JPMorgan
Bouygues price target raised to EUR 51 from EUR 45 at JPMorgan
07/27/21 Bryan Garnier
Bouygues upgraded to Buy from Neutral at Bryan Garnier
04/26/21 JPMorgan
Bouygues price target raised to EUR 45 from EUR 44 at JPMorgan
Hot Stocks
Activision Blizzard reaches agreement with EEOC to settle discrimination claims » 19:04
09/27/21
09/27
19:04
09/27/21
19:04
ATVI

Activision Blizzard

$75.10 /

-0.15 (-0.20%)

Activision Blizzard…

Activision Blizzard confirmed that, as part of its effort to have the most welcoming, inclusive workplace, it has reached an agreement with the U.S. Equal Employment Opportunity Commission to settle claims and to further strengthen policies and programs to prevent harassment and discrimination in the company's workplace. Under the agreement, the principal terms of which are summarized in Attachment A to this press release, Activision Blizzard has committed to create an $18M fund to compensate and make amends to eligible claimants. Any amounts not used for claimants will be divided between charities that advance women in the video game industry or promote awareness around harassment and gender equality issues as well as company diversity, equity, and inclusion initiatives, as approved by the EEOC. The agreement is subject to court approval. The company also announced an initiative to develop software tools and training programs to improve workplace policies and practices for employers across the technology industry. Commenting on the agreement, Activision Blizzard CEO Bobby Kotick said: "There is no place anywhere at our company for discrimination, harassment, or unequal treatment of any kind, and I am grateful to the employees who bravely shared their experiences. I am sorry that anyone had to experience inappropriate conduct, and I remain unwavering in my commitment to make Activision Blizzard one of the world's most inclusive, respected, and respectful workplaces." Kotick added: "We will continue to be vigilant in our commitment to the elimination of harassment and discrimination in the workplace. We thank the EEOC for its constructive engagement as we work to fulfill our commitments to eradicate inappropriate conduct in the workplace."

ShowHide Related Items >><<
ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

Hot Stocks
Ford to build two new campuses in Tennessee, Kentucky in EV push » 19:03
09/27/21
09/27
19:03
09/27/21
19:03
F

Ford

$14.17 /

+0.39 (+2.83%)

Ford announced plans to…

Ford announced plans to bring electric vehicles at scale to American customers with two new massive campuses in Tennessee and Kentucky that will produce the next generation of electric F-Series trucks and the batteries to power future electric Ford and Lincoln vehicles. Ford plans to make the largest ever U.S. investment in electric vehicles at one time by any automotive manufacturer and, together with its partner, SK Innovation, plans to invest $11.4B and create nearly 11,000 new jobs at the Tennessee and Kentucky mega-sites, strengthening local communities and building on Ford's position as America's leading employer of hourly autoworkers. An all-new $5.6B mega campus in Stanton, Tenn., called Blue Oval City, will create approximately 6,000 new jobs and reimagine how vehicles and batteries are manufactured, the company said. In central Kentucky, Ford plans to build a dedicated battery manufacturing complex with SK Innovation - the $5.8B BlueOvalSK Battery Park - creating 5,000 jobs. Twin battery plants on the site are intended to supply Ford's North American assembly plants with locally assembled batteries for powering next-generation electric Ford and Lincoln vehicles. Investments in the new Tennessee and Kentucky battery plants are planned to be made via BlueOvalSK, a new joint venture to be formed by Ford and SK Innovation, subject to definitive agreements, regulatory approvals and other conditions. In addition, Ford is investing $90M in Texas alone as part of a $525M total investment across the U.S. during the next five years to transform America's auto technician industry. The investment will go toward job training and career readiness initiatives for the current and next generation of technicians. These programs aim to develop highly skilled technicians and will support Ford's growing portfolio of connected electric vehicles.

ShowHide Related Items >><<
F Ford
$14.17 /

+0.39 (+2.83%)

F Ford
$14.17 /

+0.39 (+2.83%)

09/26/21 Goldman Sachs
Lordstown Motors downgraded to Sell from Neutral at Goldman Sachs
09/08/21 Benchmark
Worst of chip shortage could be over for Ford, says Benchmark
07/16/21 BofA
Ford price target raised to $18 from $17 at BofA
06/29/21 UBS
Ford price target raised to $16 from $13 at UBS
F Ford
$14.17 /

+0.39 (+2.83%)

F Ford
$14.17 /

+0.39 (+2.83%)

F Ford
$14.17 /

+0.39 (+2.83%)

F Ford
$14.17 /

+0.39 (+2.83%)

Periodicals
Tesla sued in Texas over crash involving 5 police officers, Click2Houston says » 19:00
09/27/21
09/27
19:00
09/27/21
19:00
TSLA

Tesla

$791.37 /

+16.75 (+2.16%)

Tesla and Pappas…

Tesla and Pappas Restaurants have been named in a lawsuit filed after a collision in February that injured five police officers in Splendora, Texas, Click2Houston reports. According to the suit, a Tesla Model X that had Autopilot engaged crashed into several cops who were involved in a traffic stop, the report says, noting that the suit claims all the officers were badly injured. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$791.37 /

+16.75 (+2.16%)

TSLA Tesla
$791.37 /

+16.75 (+2.16%)

09/23/21
Fly Intel: Top five analyst initiations
09/23/21 Tudor Pickering
Tudor Pickering starts 'fundamentally overvalued' Tesla at Sell
09/23/21 Tudor Pickering
Tesla initiated with a Sell at Tudor Pickering
09/17/21 Morgan Stanley
520 mile EPA range 'an important milestone' for Lucid, says Morgan Stanley
TSLA Tesla
$791.37 /

+16.75 (+2.16%)

TSLA Tesla
$791.37 /

+16.75 (+2.16%)

TSLA Tesla
$791.37 /

+16.75 (+2.16%)

TSLA Tesla
$791.37 /

+16.75 (+2.16%)

Hot Stocks
Huntsman discloses 8.4% activist stake by Starboard Value » 18:42
09/27/21
09/27
18:42
09/27/21
18:42
HUN

Huntsman

$28.06 /

+1.15 (+4.27%)

In a regulator 13D fling,…

In a regulator 13D fling, Starboard Value disclosed a 8.4% activist stake in Huntsman, which represents over 18.6M shares. The filing does allow for activism.

ShowHide Related Items >><<
HUN Huntsman
$28.06 /

+1.15 (+4.27%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

09/22/21 Deutsche Bank
Huntsman Q3 'firmly on track' to meet implied guidance, says Deutsche Bank
07/15/21 Deutsche Bank
Huntsman named 'Catalyst Call: Buy Idea' at Deutsche Bank
06/09/21 Wolfe Research
Huntsman initiated with a Peer Perform at Wolfe Research
05/11/21 Goldman Sachs
Huntsman downgraded to Neutral from Conviction Buy at Goldman Sachs
HUN Huntsman
$28.06 /

+1.15 (+4.27%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

On The Fly
Fly Intel: After-Hours Movers » 18:38
09/27/21
09/27
18:38
09/27/21
18:38
CNXC

Concentrix

$167.22 /

-1.37 (-0.81%)

, NTUS

Natus Medical

$24.86 /

+0.1 (+0.40%)

, SGMS

Scientific Games

$83.05 /

+1.83 (+2.25%)

, EDR

Endeavor Group

$27.28 /

+0.09 (+0.33%)

, HUN

Huntsman

$28.06 /

+1.15 (+4.27%)

, SPNE

SeaSpine

$15.25 /

-1.11 (-6.78%)

, PING

Ping Identity

$26.20 /

-0.74 (-2.75%)

, GLBS

Globus Maritime

$3.38 /

+0.23 (+7.31%)

, ACB

Aurora Cannabis

$6.39 /

+0.43 (+7.22%)

, BKD

Brookdale Senior Living

$6.14 /

+0.265 (+4.51%)

, HESM

Hess Midstream Partners

$29.07 /

+1.355 (+4.89%)

, MANU

Manchester United

$20.50 /

+0.52 (+2.60%)

Check out this evening's…

ShowHide Related Items >><<
SPNE SeaSpine
$15.25 /

-1.11 (-6.78%)

SGMS Scientific Games
$83.05 /

+1.83 (+2.25%)

PING Ping Identity
$26.20 /

-0.74 (-2.75%)

NTUS Natus Medical
$24.86 /

+0.1 (+0.40%)

MANU Manchester United
$20.50 /

+0.52 (+2.60%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

HESM Hess Midstream Partners
$29.07 /

+1.355 (+4.89%)

GLBS Globus Maritime
$3.38 /

+0.23 (+7.31%)

EDR Endeavor Group
$27.28 /

+0.09 (+0.33%)

CNXC Concentrix
$167.22 /

-1.37 (-0.81%)

BKD Brookdale Senior Living
$6.14 /

+0.265 (+4.51%)

ACB Aurora Cannabis
$6.39 /

+0.43 (+7.22%)

CNXC Concentrix
$167.22 /

-1.37 (-0.81%)

06/15/21 Barrington
Concentrix initiated with an Outperform at Barrington
01/07/21 Cross Research
Concentrix initiated with a Buy at Cross Research
12/08/20 Stifel
Synnex downgraded to Hold from Buy at Stifel
12/07/20 BofA
Concentrix initiated with a Buy at BofA
NTUS Natus Medical
$24.86 /

+0.1 (+0.40%)

SGMS Scientific Games
$83.05 /

+1.83 (+2.25%)

09/23/21 Craig-Hallum
Scientific Games price target raised to $105 from $100 at Craig-Hallum
09/15/21 Truist
Scientific Games' Lottery disclosure may show upside to estimates, says Truist
08/10/21 Craig-Hallum
Scientific Games price target raised to $100 from $92 at Craig-Hallum
08/10/21 Deutsche Bank
Scientific Games price target raised to $63 from $54 at Deutsche Bank
EDR Endeavor Group
$27.28 /

+0.09 (+0.33%)

08/17/21 Piper Sandler
Endeavor Group price target lowered to $33 from $35 at Piper Sandler
06/03/21 Jefferies
Endeavor Group target raised to $41 at Jefferies after first post-IPO earnings
05/24/21
Fly Intel: Top five analyst initiations
05/24/21 RBC Capital
Endeavor Group initiated with an Outperform at RBC Capital
HUN Huntsman
$28.06 /

+1.15 (+4.27%)

09/22/21 Deutsche Bank
Huntsman Q3 'firmly on track' to meet implied guidance, says Deutsche Bank
07/15/21 Deutsche Bank
Huntsman named 'Catalyst Call: Buy Idea' at Deutsche Bank
06/09/21 Wolfe Research
Huntsman initiated with a Peer Perform at Wolfe Research
05/11/21 Goldman Sachs
Huntsman downgraded to Neutral from Conviction Buy at Goldman Sachs
SPNE SeaSpine
$15.25 /

-1.11 (-6.78%)

09/27/21 Stifel
SeaSpine second spine company to preview softer Q3, says Stifel
09/27/21 BTIG
SeaSpine price target lowered to $23 from $28 at BTIG
08/02/21 Piper Sandler
SeaSpine sales upside more than offset increased opex, says Piper Sandler
05/25/21 Canaccord
SeaSpine investors should add positions ahead of second-half, says Canaccord
PING Ping Identity
$26.20 /

-0.74 (-2.75%)

08/05/21 Stephens
Stephens raises Ping Identity price target to $35, names a Best Idea
07/16/21 Mizuho
Ping Identity price target lowered to $29 from $30 at Mizuho
06/11/21 Needham
Needham starts Ping Identity at Hold, sees upside potential 'baked in'
06/11/21 Needham
Ping Identity initiated with a Hold at Needham
GLBS Globus Maritime
$3.38 /

+0.23 (+7.31%)

08/02/21 Maxim
Globus Maritime initiated with a Buy at Maxim
ACB Aurora Cannabis
$6.39 /

+0.43 (+7.22%)

09/23/21 CIBC
Aurora Cannabis price target lowered to C$7 from C$8 at CIBC
09/17/21 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$8.30 from C$12.00 at Cantor Fitzgerald
09/03/21 Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
BKD Brookdale Senior Living
$6.14 /

+0.265 (+4.51%)

06/22/21 Stifel
Brookdale Senior Living resumed with a Buy at Stifel
06/11/21 Barclays
Brookdale Senior Living upgraded to Overweight from Equal Weight at Barclays
06/07/21 Jefferies
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies
03/09/21 RBC Capital
Brookdale Senior Living price target raised to $7 from $4 at RBC Capital
HESM Hess Midstream Partners
$29.07 /

+1.355 (+4.89%)

09/27/21 Citi
Hess Midstream Partners downgraded to Neutral from Buy at Citi
07/29/21 Wells Fargo
Hess Midstream Partners price target raised to $30 from $25 at Wells Fargo
07/16/21 Credit Suisse
Hess Midstream Partners assumed with a Neutral at Credit Suisse
06/30/21 Wells Fargo
Hess Corp. price target raised to $104 from $98 at Wells Fargo
MANU Manchester United
$20.50 /

+0.52 (+2.60%)

04/06/21 Deutsche Bank
Manchester United price target raised to $17 from $16 at Deutsche Bank
SPNE SeaSpine
$15.25 /

-1.11 (-6.78%)

SGMS Scientific Games
$83.05 /

+1.83 (+2.25%)

PING Ping Identity
$26.20 /

-0.74 (-2.75%)

MANU Manchester United
$20.50 /

+0.52 (+2.60%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

HESM Hess Midstream Partners
$29.07 /

+1.355 (+4.89%)

GLBS Globus Maritime
$3.38 /

+0.23 (+7.31%)

EDR Endeavor Group
$27.28 /

+0.09 (+0.33%)

CNXC Concentrix
$167.22 /

-1.37 (-0.81%)

BKD Brookdale Senior Living
$6.14 /

+0.265 (+4.51%)

ACB Aurora Cannabis
$6.39 /

+0.43 (+7.22%)

  • 16
    Aug
  • 15
    Jun
  • 10
    Oct
  • 29
    Apr
  • 16
    Apr
  • 12
    Mar
  • 11
    Mar
  • 22
    Jan
  • 15
    Dec
  • 11
    Nov
MANU Manchester United
$20.50 /

+0.52 (+2.60%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

EDR Endeavor Group
$27.28 /

+0.09 (+0.33%)

ACB Aurora Cannabis
$6.39 /

+0.43 (+7.22%)

SPNE SeaSpine
$15.25 /

-1.11 (-6.78%)

SGMS Scientific Games
$83.05 /

+1.83 (+2.25%)

PING Ping Identity
$26.20 /

-0.74 (-2.75%)

MANU Manchester United
$20.50 /

+0.52 (+2.60%)

EDR Endeavor Group
$27.28 /

+0.09 (+0.33%)

CNXC Concentrix
$167.22 /

-1.37 (-0.81%)

BKD Brookdale Senior Living
$6.14 /

+0.265 (+4.51%)

ACB Aurora Cannabis
$6.39 /

+0.43 (+7.22%)

SGMS Scientific Games
$83.05 /

+1.83 (+2.25%)

MANU Manchester United
$20.50 /

+0.52 (+2.60%)

HUN Huntsman
$28.06 /

+1.15 (+4.27%)

GLBS Globus Maritime
$3.38 /

+0.23 (+7.31%)

EDR Endeavor Group
$27.28 /

+0.09 (+0.33%)

CNXC Concentrix
$167.22 /

-1.37 (-0.81%)

BKD Brookdale Senior Living
$6.14 /

+0.265 (+4.51%)

ACB Aurora Cannabis
$6.39 /

+0.43 (+7.22%)

Periodicals
EEOC sues Activision Blizzard over alleged workplace discrimination, Verge says » 18:32
09/27/21
09/27
18:32
09/27/21
18:32
ATVI

Activision Blizzard

$75.10 /

-0.15 (-0.20%)

The U.S. Equal Employment…

The U.S. Equal Employment Opportunity Commission, or EEOC, is suing Activision Blizzard over claims that it fostered a toxic work environment defined by sexual misconduct and discrimination, The Verge's Adi Robertson reports, citing a California court filing. The lawsuit is based on a three-year commission probe that included cooperation from the company, the author says, noting the suit seeks a court order mandating the company cease unlawful behavior and pay restitution to workers who suffered discrimination or retaliation. Reference Link

ShowHide Related Items >><<
ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

ATVI Activision Blizzard
$75.10 /

-0.15 (-0.20%)

Hot Stocks
Union Pacific CEO: Labor shortages, supply chain issues are transitory » 18:26
09/27/21
09/27
18:26
09/27/21
18:26
UNP

Union Pacific

$203.97 /

+0.17 (+0.08%)

In an interview on…

In an interview on CNBC's Mad Money, Lance Fritz said the country needs to get the Delta variant under control to alleviate supply chain problems. Union Pacific needs to focus on labor at both the last mile and first mile, he added. Fritz expects vacant jobs to be filled over time. "Intermodal is important to us. West coast ports are never a liability," he noted. Fritz added that the company is generating strong numbers despite the current supply chain issues.

ShowHide Related Items >><<
UNP Union Pacific
$203.97 /

+0.17 (+0.08%)

UNP Union Pacific
$203.97 /

+0.17 (+0.08%)

09/17/21 Deutsche Bank
Union Pacific price target lowered to $225 from $256 at Deutsche Bank
09/14/21 Loop Capital
Union Pacific price target lowered to $252 from $270 at Loop Capital
07/09/21 JPMorgan
Expected Biden order 'clear negative' for rail valuations, says JPMorgan
07/06/21 Loop Capital
Union Pacific upgraded to Buy from Hold at Loop Capital
UNP Union Pacific
$203.97 /

+0.17 (+0.08%)

UNP Union Pacific
$203.97 /

+0.17 (+0.08%)

UNP Union Pacific
$203.97 /

+0.17 (+0.08%)

UNP Union Pacific
$203.97 /

+0.17 (+0.08%)

Periodicals
Court says NYC can proceed with educator vaccine requirement, NY Times says » 18:12
09/27/21
09/27
18:12
09/27/21
18:12
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$442.68 /

-1.24 (-0.28%)

, PFE

Pfizer

$43.55 /

-0.4 (-0.91%)

, BNTX

BioNTech

$307.09 /

-26.47 (-7.94%)

, MRNA

Moderna

$408.99 /

-21.18 (-4.92%)

, JNJ

Johnson & Johnson

$163.17 /

-1.195 (-0.73%)

A federal appeals panel…

A federal appeals panel determined that New York City's vaccine requirement for nearly all adults working in its public schools can move forward as planned, the New York Times' Eliza Shapiro and Benjamin Weiser report. The move reverses a decision made over the weekend that halted enforcement of the mandate until later this week at the earliest, the authors note. Companies in the COVID-19 vaccine space include Pfizer (PFE) and BioNTech (BNTX), Moderna (MRNA), and Johnson & Johnson (JNJ). Reference Link

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$442.68 /

-1.24 (-0.28%)

SPX S&P 500
/

+

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

MRNA Moderna
$408.99 /

-21.18 (-4.92%)

JNJ Johnson & Johnson
$163.17 /

-1.195 (-0.73%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

SPX S&P 500
/

+

08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
SPY SPDR S&P 500 ETF Trust
$442.68 /

-1.24 (-0.28%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

09/27/21 Barrington
Barrington says Somatrogon delay does not change Opko Health view
09/24/21 Piper Sandler
Piper confident in Opko's somatrogon approval despite BLA review delay
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
MRNA Moderna
$408.99 /

-21.18 (-4.92%)

09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$163.17 /

-1.195 (-0.73%)

09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
PFE Pfizer
$43.55 /

-0.4 (-0.91%)

MRNA Moderna
$408.99 /

-21.18 (-4.92%)

JNJ Johnson & Johnson
$163.17 /

-1.195 (-0.73%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

SPX S&P 500
/

+

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

MRNA Moderna
$408.99 /

-21.18 (-4.92%)

JNJ Johnson & Johnson
$163.17 /

-1.195 (-0.73%)

SPX S&P 500
/

+

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

MRNA Moderna
$408.99 /

-21.18 (-4.92%)

JNJ Johnson & Johnson
$163.17 /

-1.195 (-0.73%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

SPY SPDR S&P 500 ETF Trust
$442.68 /

-1.24 (-0.28%)

SPX S&P 500
/

+

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

MRNA Moderna
$408.99 /

-21.18 (-4.92%)

JNJ Johnson & Johnson
$163.17 /

-1.195 (-0.73%)

SPY SPDR S&P 500 ETF Trust
$442.68 /

-1.24 (-0.28%)

SPX S&P 500
/

+

Hot Stocks
SPDR Gold Shares holdings fall from 993.52MT to 990.32MT » 18:12
09/27/21
09/27
18:12
09/27/21
18:12
GLD

SPDR Gold Shares

$163.64 /

+0.33 (+0.20%)

This is the lowest level…

This is the lowest level of holdings since April of 2020.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$163.64 /

+0.33 (+0.20%)

GLD SPDR Gold Shares
$163.64 /

+0.33 (+0.20%)

GLD SPDR Gold Shares
$163.64 /

+0.33 (+0.20%)

Downgrade
Hess Midstream Partners downgraded to Neutral from Buy at Citi » 18:09
09/27/21
09/27
18:09
09/27/21
18:09
HESM

Hess Midstream Partners

$29.07 /

+1.355 (+4.89%)

Citi analyst Timm…

Citi analyst Timm Schneider downgraded Hess Midstream Partners to Neutral from Buy with a price target of $31. The rating change is not a reflection of the company's operations as its management has "executed well" against elevated expectations, the analyst tells investors in a research note. Schneider adds however that he sees "better value elsewhere", with his better than expected EBITDA view already reflected in Hess Midstream valuation.

ShowHide Related Items >><<
HESM Hess Midstream Partners
$29.07 /

+1.355 (+4.89%)

HESM Hess Midstream Partners
$29.07 /

+1.355 (+4.89%)

07/29/21 Wells Fargo
Hess Midstream Partners price target raised to $30 from $25 at Wells Fargo
07/16/21 Credit Suisse
Hess Midstream Partners assumed with a Neutral at Credit Suisse
06/30/21 Wells Fargo
Hess Corp. price target raised to $104 from $98 at Wells Fargo
06/13/21 Goldman Sachs
Hess Midstream Partners initiated with a Buy at Goldman Sachs
HESM Hess Midstream Partners
$29.07 /

+1.355 (+4.89%)

  • 11
    Mar
Periodicals
Google cites Apple's iOS in argument against record EU fine, Reuters says » 17:57
09/27/21
09/27
17:57
09/27/21
17:57
GOOG

Alphabet

$2,830.94 /

-22.76 (-0.80%)

, GOOGL

Alphabet Class A

$2,821.88 /

-21.53 (-0.76%)

, AAPL

Apple

$145.39 /

-1.52 (-1.03%)

, AMZN

Amazon.com

$3,406.70 /

-20.28 (-0.59%)

, FB

Facebook

$353.62 /

+0.485 (+0.14%)

Search giant Google (GOOG…

Search giant Google (GOOG GOOGL) argued against EU regulators for giving Apple (AAPL) a pass on its operating system, but fining Google $5.1B for its Android operating system dominance, wrote Foo Yun Chee for Reuters. In 2018 the European Commission fined Google over over its Android operating system. "saying that it had used Android since 2011 to thwart rivals and cement its dominance in general internet search," noted the Reuters story. "Regardless of how the court rules, Google, Apple, Amazon (AMZN) and Facebook (FB) will have to change their business models in the coming years to ensure a level playing field for rivals following tough new rules proposed by European Union antitrust chief Margrethe Vestager,"added the story. Reference Link

ShowHide Related Items >><<
GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

AAPL Apple
$145.39 /

-1.52 (-1.03%)

GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
09/17/21 Jefferies
Alphabet price target raised to $3,325 from $3,150 at Jefferies
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Alphabet Class A initiated with a Buy at Goldman Sachs
GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

AAPL Apple
$145.39 /

-1.52 (-1.03%)

09/27/21 Credit Suisse
Apple iPhone 13 extended waits versus 12 cycle continue, says Credit Suisse
09/22/21 BMO Capital
Facebook guidance unchanged, not much new on technical side, says BMO Capital
09/22/21 Tigress Financial
Apple price target raised to $198 from $182 at Tigress Financial
09/21/21 BofA
BofA says nationalist sentiment resurgence in China could hurt iPhone sales
AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

09/27/21 Morgan Stanley
Morgan Stanley cuts Amazon target to $4,100 on rising wage pressure
09/24/21 Morgan Stanley
Vtex upgraded to Overweight from Equal Weight at Morgan Stanley
09/24/21 Oppenheimer
Opco downgrades Cloudflare amid competition from Amazon, Microsoft
FB Facebook
$353.62 /

+0.485 (+0.14%)

09/24/21 BTIG
Etsy price target raised to $238 from $215 at BTIG
09/22/21 Morgan Stanley
Facebook blog post not signal of near-term ad revenue risk, says Morgan Stanley
09/22/21 Baird
Facebook IDFA update largely consistent with industry checks, says Baird
GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

AAPL Apple
$145.39 /

-1.52 (-1.03%)

GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

AAPL Apple
$145.39 /

-1.52 (-1.03%)

GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

AAPL Apple
$145.39 /

-1.52 (-1.03%)

AAPL Apple
$145.39 /

-1.52 (-1.03%)

Hot Stocks
C3.ai director House sells 46,000 class A shares » 17:46
09/27/21
09/27
17:46
09/27/21
17:46
AI

C3.ai

$49.48 /

-0.05 (-0.10%)

In a regulatory filing,…

In a regulatory filing, C3.ai director Patricia House disclosed the sale of 46,000 class A common shares of the company on September 23 at a price of $49.50 per share.

ShowHide Related Items >><<
AI C3.ai
$49.48 /

-0.05 (-0.10%)

AI C3.ai
$49.48 /

-0.05 (-0.10%)

09/03/21 Deutsche Bank
C3.ai price target lowered to $50 from $63 at Deutsche Bank
09/02/21 Wedbush
C3.ai price target lowered to $70 from $100 at Wedbush
09/02/21 JMP Securities
C3.ai price target lowered to $96 from $167 at JMP Securities
09/02/21 Piper Sandler
C3.ai price target lowered to $78 from $98 at Piper Sandler
AI C3.ai
$49.48 /

-0.05 (-0.10%)

  • 09
    Dec
AI C3.ai
$49.48 /

-0.05 (-0.10%)

AI C3.ai
$49.48 /

-0.05 (-0.10%)

Periodicals
Merck in advanced talks to acquire Acceleron, WSJ reports » 17:38
09/27/21
09/27
17:38
09/27/21
17:38
XLRN

Acceleron

$178.81 /

+11.29 (+6.74%)

, MRK

Merck

$73.35 /

-0.26 (-0.35%)

Merck (MRK) is in…

Merck (MRK) is in advanced discussions to acquire Acceleron Pharma (XLRN), with the deal potentially being announced this week if talks do not break down, The Wall Street Journal's Cara Lombardo and Ben Dummett report, citing people familiar with the matter. The move would be intended to bolster Merck's rare-disease business, the report states. Reference Link

ShowHide Related Items >><<
XLRN Acceleron
$178.81 /

+11.29 (+6.74%)

MRK Merck
$73.35 /

-0.26 (-0.35%)

XLRN Acceleron
$178.81 /

+11.29 (+6.74%)

09/27/21 Cowen
Cowen thinks Acceleron talks leaked by hopeful buyer, sees $180/share as too low
09/27/21 RBC Capital
Acceleron price target raised to $179 from $113 at RBC Capital
08/05/21 Piper Sandler
Acceleron price target raised to $146 from $143 at Piper Sandler
07/19/21 Wolfe Research
Acceleron assumed with an Outperform at Wolfe Research
MRK Merck
$73.35 /

-0.26 (-0.35%)

09/23/21 Citi
Citi opens 'Positive Catalyst Watch' on Merck into Covid data
09/22/21 Goldman Sachs
Vir Biotechnology downgraded to Neutral from Buy at Goldman Sachs
09/21/21 BMO Capital
Regeneron price target raised to $706 from $669 at BMO Capital
09/21/21 Barclays
Merck faces 'compelling series' of catalysts into 2022, says Barclays
XLRN Acceleron
$178.81 /

+11.29 (+6.74%)

MRK Merck
$73.35 /

-0.26 (-0.35%)

XLRN Acceleron
$178.81 /

+11.29 (+6.74%)

MRK Merck
$73.35 /

-0.26 (-0.35%)

XLRN Acceleron
$178.81 /

+11.29 (+6.74%)

MRK Merck
$73.35 /

-0.26 (-0.35%)

MRK Merck
$73.35 /

-0.26 (-0.35%)

Downgrade
Logitech downgraded to Underweight from Equal Weight at Morgan Stanley » 17:31
09/27/21
09/27
17:31
09/27/21
17:31
LOGI

Logitech

$96.79 /

-2.51 (-2.53%)

Morgan Stanley analyst…

Morgan Stanley analyst Katy Huberty downgraded Logitech to Underweight from Equal Weight with a price target of $82, down from $119. In a research note titled 'Data Turning Bearish With More Downside From Here,' Huberty noted that the firm's data shows cyclical tailwinds fading and difficult year-over-year growth comparisons approaching for Logitech. The analyst sees a greater probability of negative estimate revisions and multiple compression, which suggests further downside from current levels.

ShowHide Related Items >><<
LOGI Logitech
$96.79 /

-2.51 (-2.53%)

LOGI Logitech
$96.79 /

-2.51 (-2.53%)

07/28/21 Credit Suisse
Logitech price target raised to CHF 139 from CHF 133 at Credit Suisse
07/28/21 Loop Capital
Logitech downgraded to Hold from Buy at Loop Capital
07/28/21 Loop Capital
Logitech downgraded to Hold from Buy at Loop Capital
06/24/21 Goldman Sachs
Logitech downgraded to Neutral from Buy at Goldman Sachs
LOGI Logitech
$96.79 /

-2.51 (-2.53%)

LOGI Logitech
$96.79 /

-2.51 (-2.53%)

LOGI Logitech
$96.79 /

-2.51 (-2.53%)

LOGI Logitech
$96.79 /

-2.51 (-2.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.